First Hawaiian Bank Neurocrine Biosciences Inc Transaction History

First Hawaiian Bank

  • $3.01 Billion
  • Q4 2024

A detailed history of First Hawaiian Bank transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, First Hawaiian Bank holds 12,243 shares of NBIX stock, worth $1.35 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
12,243
Previous 10,093 21.3%
Holding current value
$1.35 Million
Previous $1.16 Million 43.8%
% of portfolio
0.06%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 08, 2025
BUY
$111.62 - $139.44 $239,983 - $299,796
2,150 Added 21.3%
12,243 $1.67 Million
Q3 2024

Oct 04, 2024
BUY
$114.58 - $153.15 $528,213 - $706,021
4,610 Added 84.08%
10,093 $1.16 Million
Q2 2024

Jul 02, 2024
BUY
$130.86 - $143.19 $41,875 - $45,820
320 Added 6.2%
5,483 $754,000
Q1 2024

Apr 05, 2024
SELL
$130.4 - $143.74 $13,692 - $15,092
-105 Reduced 1.99%
5,163 $712,000
Q4 2023

Jan 08, 2024
BUY
$106.07 - $132.76 $178,727 - $223,700
1,685 Added 47.03%
5,268 $694,000
Q3 2023

Oct 10, 2023
BUY
$94.02 - $117.1 $84,618 - $105,390
900 Added 33.54%
3,583 $403,000
Q2 2023

Jul 06, 2023
SELL
$89.53 - $104.87 $783,387 - $917,612
-8,750 Reduced 76.53%
2,683 $253,000
Q1 2023

Apr 18, 2023
SELL
$94.11 - $123.02 $300,681 - $393,048
-3,195 Reduced 21.84%
11,433 $1.16 Million
Q4 2022

Jan 12, 2023
SELL
$106.72 - $127.06 $69,368 - $82,589
-650 Reduced 4.25%
14,628 $1.75 Million
Q3 2022

Oct 05, 2022
BUY
$92.03 - $107.81 $1,380 - $1,617
15 Added 0.1%
15,278 $1.62 Million
Q2 2022

Jul 22, 2022
BUY
$75.79 - $100.07 $487,708 - $643,950
6,435 Added 72.89%
15,263 $1.49 Million
Q1 2022

Apr 06, 2022
BUY
$72.45 - $94.81 $2,535 - $3,318
35 Added 0.4%
8,828 $827,000
Q4 2021

Jan 12, 2022
BUY
$79.65 - $106.22 $700,362 - $933,992
8,793 New
8,793 $749,000
Q1 2021

Apr 09, 2021
SELL
$87.57 - $119.4 $269,540 - $367,513
-3,078 Closed
0 $0
Q4 2020

Jan 12, 2021
SELL
$86.91 - $108.33 $12,601 - $15,707
-145 Reduced 4.5%
3,078 $295,000
Q3 2020

Oct 06, 2020
BUY
$96.16 - $135.15 $309,923 - $435,588
3,223 New
3,223 $310,000
Q2 2019

Jul 15, 2019
SELL
$72.24 - $91.27 $9,174 - $11,591
-127 Closed
0 $0
Q1 2019

Apr 02, 2019
SELL
$69.31 - $91.53 $16,703 - $22,058
-241 Reduced 65.49%
127 $11,000
Q4 2018

Jan 11, 2019
BUY
$68.32 - $124.36 $3,962 - $7,212
58 Added 18.71%
368 $26,000
Q3 2018

Oct 16, 2018
BUY
$98.88 - $125.85 $30,652 - $39,013
310 New
310 $38,000

Others Institutions Holding NBIX

# of Institutions
656
Shares Held
95.2M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.6B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email